Cargando…

Proton magnetic resonance spectroscopy assessment of metabolite status of the anterior cingulate cortex in chronic pain patients and healthy controls

BACKGROUND: Chronic pain is a common cause of reduced quality of life. Recent studies suggest that chronic pain patients have a different brain neurometabolic status to healthy people. Proton magnetic resonance spectroscopy ((1)H-MRS) can determine the concentrations of metabolites in a specific reg...

Descripción completa

Detalles Bibliográficos
Autores principales: Ito, Takahiro, Tanaka-Mizuno, Sachiko, Iwashita, Narihito, Tooyama, Ikuo, Shiino, Akihiko, Miura, Katsuyuki, Fukui, Sei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5293371/
https://www.ncbi.nlm.nih.gov/pubmed/28203104
http://dx.doi.org/10.2147/JPR.S123403
_version_ 1782505067370250240
author Ito, Takahiro
Tanaka-Mizuno, Sachiko
Iwashita, Narihito
Tooyama, Ikuo
Shiino, Akihiko
Miura, Katsuyuki
Fukui, Sei
author_facet Ito, Takahiro
Tanaka-Mizuno, Sachiko
Iwashita, Narihito
Tooyama, Ikuo
Shiino, Akihiko
Miura, Katsuyuki
Fukui, Sei
author_sort Ito, Takahiro
collection PubMed
description BACKGROUND: Chronic pain is a common cause of reduced quality of life. Recent studies suggest that chronic pain patients have a different brain neurometabolic status to healthy people. Proton magnetic resonance spectroscopy ((1)H-MRS) can determine the concentrations of metabolites in a specific region of the brain without being invasive. PATIENTS AND METHODS: We recruited 56 chronic pain patients and 60 healthy controls to compare brain metabolic characteristics. The concentrations of glutamic acid (Glu), myo-inositol (Ins), N-acetylaspartate (NAA), Glu + glutamine (Glx), and creatine + phosphocreatine (total creatine [tCr]) in the anterior cingulate cortex of participants were measured using (1)H-MRS. We used age- and gender-adjusted general linear models and receiver-operating characteristic analyses for this investigation. Patients were also assessed using the Hospital Anxiety and Depression Scale (HADS) to reveal the existence of any mental health issues. RESULTS: Our analysis indicates that pain patients have statistically significantly higher levels of Glu/tCr (p=0.039) and Glx/tCr (p<0.001) and lower levels of NAA/tCr than controls, although this did not reach statistical significance (p=0.052). Receiver-operating characteristic analysis performed on the combination of Glx/tCr, Ins/tCr, and NAA/tCr effectively discriminated chronic pain patients from healthy controls. Patients with higher HADS-Depression scores had increased Glx/rCr levels (p=0.015), and those with higher HADS-Anxiety scores had increased NAA/tCr levels (p=0.018). CONCLUSION: Chronic pain patients have a different metabolite status in the anterior cingulate cortex to controls. Within the pain patient group, HADS scores had a positive relationship with NAA/tCr and Glx/tCr levels. (1)H-MRS successfully detected metabolic changes in patients’ brains in a noninvasive manner, revealing its potential as a superior diagnostic tool for pain patients.
format Online
Article
Text
id pubmed-5293371
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-52933712017-02-15 Proton magnetic resonance spectroscopy assessment of metabolite status of the anterior cingulate cortex in chronic pain patients and healthy controls Ito, Takahiro Tanaka-Mizuno, Sachiko Iwashita, Narihito Tooyama, Ikuo Shiino, Akihiko Miura, Katsuyuki Fukui, Sei J Pain Res Original Research BACKGROUND: Chronic pain is a common cause of reduced quality of life. Recent studies suggest that chronic pain patients have a different brain neurometabolic status to healthy people. Proton magnetic resonance spectroscopy ((1)H-MRS) can determine the concentrations of metabolites in a specific region of the brain without being invasive. PATIENTS AND METHODS: We recruited 56 chronic pain patients and 60 healthy controls to compare brain metabolic characteristics. The concentrations of glutamic acid (Glu), myo-inositol (Ins), N-acetylaspartate (NAA), Glu + glutamine (Glx), and creatine + phosphocreatine (total creatine [tCr]) in the anterior cingulate cortex of participants were measured using (1)H-MRS. We used age- and gender-adjusted general linear models and receiver-operating characteristic analyses for this investigation. Patients were also assessed using the Hospital Anxiety and Depression Scale (HADS) to reveal the existence of any mental health issues. RESULTS: Our analysis indicates that pain patients have statistically significantly higher levels of Glu/tCr (p=0.039) and Glx/tCr (p<0.001) and lower levels of NAA/tCr than controls, although this did not reach statistical significance (p=0.052). Receiver-operating characteristic analysis performed on the combination of Glx/tCr, Ins/tCr, and NAA/tCr effectively discriminated chronic pain patients from healthy controls. Patients with higher HADS-Depression scores had increased Glx/rCr levels (p=0.015), and those with higher HADS-Anxiety scores had increased NAA/tCr levels (p=0.018). CONCLUSION: Chronic pain patients have a different metabolite status in the anterior cingulate cortex to controls. Within the pain patient group, HADS scores had a positive relationship with NAA/tCr and Glx/tCr levels. (1)H-MRS successfully detected metabolic changes in patients’ brains in a noninvasive manner, revealing its potential as a superior diagnostic tool for pain patients. Dove Medical Press 2017-01-31 /pmc/articles/PMC5293371/ /pubmed/28203104 http://dx.doi.org/10.2147/JPR.S123403 Text en © 2017 Ito et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Ito, Takahiro
Tanaka-Mizuno, Sachiko
Iwashita, Narihito
Tooyama, Ikuo
Shiino, Akihiko
Miura, Katsuyuki
Fukui, Sei
Proton magnetic resonance spectroscopy assessment of metabolite status of the anterior cingulate cortex in chronic pain patients and healthy controls
title Proton magnetic resonance spectroscopy assessment of metabolite status of the anterior cingulate cortex in chronic pain patients and healthy controls
title_full Proton magnetic resonance spectroscopy assessment of metabolite status of the anterior cingulate cortex in chronic pain patients and healthy controls
title_fullStr Proton magnetic resonance spectroscopy assessment of metabolite status of the anterior cingulate cortex in chronic pain patients and healthy controls
title_full_unstemmed Proton magnetic resonance spectroscopy assessment of metabolite status of the anterior cingulate cortex in chronic pain patients and healthy controls
title_short Proton magnetic resonance spectroscopy assessment of metabolite status of the anterior cingulate cortex in chronic pain patients and healthy controls
title_sort proton magnetic resonance spectroscopy assessment of metabolite status of the anterior cingulate cortex in chronic pain patients and healthy controls
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5293371/
https://www.ncbi.nlm.nih.gov/pubmed/28203104
http://dx.doi.org/10.2147/JPR.S123403
work_keys_str_mv AT itotakahiro protonmagneticresonancespectroscopyassessmentofmetabolitestatusoftheanteriorcingulatecortexinchronicpainpatientsandhealthycontrols
AT tanakamizunosachiko protonmagneticresonancespectroscopyassessmentofmetabolitestatusoftheanteriorcingulatecortexinchronicpainpatientsandhealthycontrols
AT iwashitanarihito protonmagneticresonancespectroscopyassessmentofmetabolitestatusoftheanteriorcingulatecortexinchronicpainpatientsandhealthycontrols
AT tooyamaikuo protonmagneticresonancespectroscopyassessmentofmetabolitestatusoftheanteriorcingulatecortexinchronicpainpatientsandhealthycontrols
AT shiinoakihiko protonmagneticresonancespectroscopyassessmentofmetabolitestatusoftheanteriorcingulatecortexinchronicpainpatientsandhealthycontrols
AT miurakatsuyuki protonmagneticresonancespectroscopyassessmentofmetabolitestatusoftheanteriorcingulatecortexinchronicpainpatientsandhealthycontrols
AT fukuisei protonmagneticresonancespectroscopyassessmentofmetabolitestatusoftheanteriorcingulatecortexinchronicpainpatientsandhealthycontrols